|
DLEU1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.150600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.393400E-01 |
| Normal-vs-Stage2 |
4.001800E-01 |
| Normal-vs-Stage3 |
6.648000E-01 |
| Normal-vs-Stage4 |
3.722600E-03 |
| Stage1-vs-Stage2 |
2.499400E-01 |
| Stage1-vs-Stage3 |
2.675000E-01 |
| Stage1-vs-Stage4 |
2.32830000002071E-06 |
| Stage2-vs-Stage3 |
5.771400E-01 |
| Stage2-vs-Stage4 |
1.084430E-01 |
| Stage3-vs-Stage4 |
3.079400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.649200E-01 |
| Normal-vs-AfricanAmerican |
5.636800E-01 |
| Normal-vs-Asian |
5.674200E-01 |
| Caucasian-vs-AfricanAmerican |
6.635000E-01 |
| Caucasian-vs-Asian |
4.817600E-01 |
| AfricanAmerican-vs-Asian |
3.282000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.148800E-01 |
| Normal-vs-Female |
6.550600E-01 |
| Male-vs-Female |
2.910200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.926400E-01 |
| Normal-vs-Extreme_Weight |
6.032200E-01 |
| Normal-vs-Obese |
7.620600E-01 |
| Normal-vs-Extreme_Obese |
1.961050E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.952200E-01 |
| Normal_Weight-vs-Obese |
7.051000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.176000E-01 |
| Extreme_Weight-vs-Obese |
8.319400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.550580E-01 |
| Obese-vs-Extreme_Obese |
1.738410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.708400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.650800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.020400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.135040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.519600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.880400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.126000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.042020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.677570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.711000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.113790E-01 |
| Normal-VS-Type2 PRCC |
5.943200E-01 |
| Normal-VS-KIRP CIMP |
8.246200E-01 |
| Normal-VS-Unclassified PRCC |
4.653000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.719700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.035000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.558400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.944800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.056200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.748800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.052800E-01 |
| Normal-vs-N1 |
8.705800E-02 |
| Normal-vs-N2 |
6.505900E-02 |
| N0-vs-N1 |
2.744200E-01 |
| N0-vs-N2 |
5.280400E-01 |
| N1-vs-N2 |
9.393600E-01 |
|
|
